No. 6: Cardinal Health (medical segment)
2017 revenues: $16,000,000,000
Fiscal year ending: June 30, 2018
Mike Kaufmann, CEO; Jon Giacomin, CEO, medical segment; Craig Cowman, EVP, global sourcing; Joseph DePinto, president; Cardinal Health specialty solutions; Michele Holcomb, EVP, strategy and corporate development; Jorge Gomez, CFO; Pamela Kimmet, chief human resources officer; Steve Mason, president, Cardinal Health at Home; Craig Morford, chief legal & compliance officer; Tiffany Olson, president, nuclear pharmacy services; Bill Owad, SVP, operational excellence; Patrick Holt, president, Cordis
Cardinal Health this year continued the evolution begun in 2017 with the $6.1 billion acquisition of Medtronic’s patient care, deep vein thrombosis and nutritional insufficiency businesses. The company sold its majority stake in post-acute care provider NaviHealth to private equity firm Clayton, Dubilier & Rice (Cardinal held on to a 45% share in NaviHealth and kept the call right to re-aquire the business) and dealt its Cardinal Health China business to Shanghai Pharmaceuticals for $1.2 billion. In a planned succession, chairman & CEO George Barrett retired and was replaced by CFO Mike Kaufmann (Medical segment finance chief Jorge Gomez was named to succeed Kaufmann). In June 2018 the FDA’s Circulatory System Devices advisory panel recommended approval for the Incraft abdominal aortic aneurysm stent graft made by its Cordis subsidiary.